{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:51:00Z","timestamp":1791258660753,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ganzhou Science and Technology Plan Project","award":["2023LNS17536"],"award-info":[{"award-number":["2023LNS17536"]}]},{"name":"Sailing Project Fund of The First Affiliated Hospital of Nanchang University","award":["SC-0064"],"award-info":[{"award-number":["SC-0064"]}],"id":[{"id":"https:\/\/ror.org\/05gbwr869","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["82400726"],"award-info":[{"award-number":["82400726"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05965-8","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:01:56Z","timestamp":1791255716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ursolic acid ameliorates metabolic dysfunction-associated fatty liver disease by regulating the NOX4\/ROS\/NLRP3 pathway"],"prefix":"10.1007","author":[{"given":"Jian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7147-5139","authenticated-orcid":false,"given":"Hu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"1","key":"5965_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J et al (2019) Burden of liver diseases in the world[J]. J Hepatol 70(1):151\u2013171","journal-title":"J Hepatol"},{"issue":"6","key":"5965_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1089\/ars.2020.8032","volume":"33","author":"K Bernard","year":"2020","unstructured":"Bernard K, Thannickal VJ (2020) NADPH Oxidase Inhibition in Fibrotic Pathologies[J]. Antioxid Redox Signal 33(6):455\u2013479","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"5965_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/hep.32320","volume":"76","author":"DM Calcagno","year":"2022","unstructured":"Calcagno DM, Chu A, Gaul S et al (2022) NOD-like receptor protein 3 activation causes spontaneous inflammation and fibrosis that mimics human NASH. Hepatology 76(3):727\u2013741","journal-title":"Hepatology"},{"key":"5965_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.foodchem.2016.10.029","volume":"220","author":"ST Cargnin","year":"2017","unstructured":"Cargnin ST, Gnoatto SB (2017) Ursolic acid from apple pomace and traditional plants: a valuable triterpenoid with functional properties. Food Chem 220:477\u2013489","journal-title":"Food Chem"},{"key":"5965_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-pathmechdis-032521-102529","volume":"17","author":"M de Carvalho Ribeiro","year":"2022","unstructured":"de Carvalho Ribeiro M, Szabo G (2022) Role of the inflammasome in liver disease. Annu Rev Pathol Mech Dis 17:345\u2013365","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"6","key":"5965_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S2468-1253(22)00008-5","volume":"7","author":"LA D\u00edaz","year":"2022","unstructured":"D\u00edaz LA, Fuentes-L\u00f3pez E, Ayares G et al (2022) The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas[J]. The Lancet Gastroenterology & Hepatology 7(6):552\u2013559","journal-title":"The Lancet Gastroenterology & Hepatology"},{"issue":"6","key":"5965_CR7","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/liv.15188","volume":"42","author":"TM Farahat","year":"2022","unstructured":"Farahat TM, Ungan M, Vilaseca J et al (2022) The paradigm shift from NAFLD to MAFLD: a global primary care viewpoint. Liver Int 42(6):1259\u20131267","journal-title":"Liver Int"},{"issue":"2 Suppl 1","key":"5965_CR8","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1002\/hep.20973","volume":"43","author":"GC Farrell","year":"2006","unstructured":"Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology (Baltimore, MD) 43(2 Suppl 1):S99\u2013S112","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"5","key":"5965_CR9","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.3390\/ijms12053117","volume":"12","author":"A Fern\u00e1ndez-S\u00e1nchez","year":"2011","unstructured":"Fern\u00e1ndez-S\u00e1nchez A, Madrigal-Santill\u00e1n E, Bautista M et al (2011) Inflammation, oxidative stress, and obesity. Int J Mol Sci 12(5):3117\u20133132","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5965_CR10","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M et al (2018) Mechanisms of NAFLD development and therapeutic strategies[J]. Nat Med 24(7):908\u2013922","journal-title":"Nat Med"},{"issue":"6","key":"5965_CR11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/biomedicines9060687","volume":"9","author":"D Gabbia","year":"2021","unstructured":"Gabbia D, Cannella L, de Martin S (2021) The Role of Oxidative Stress in NAFLD-NASH-HCC Transition-Focus on NADPH Oxidases[J]. Biomedicines 9(6):687","journal-title":"Biomedicines"},{"issue":"2","key":"5965_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD (2020) Oxidative stress in cancer. Cancer Cell 38(2):167\u2013197","journal-title":"Cancer Cell"},{"issue":"8","key":"5965_CR13","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1080\/10715762.2019.1649670","volume":"53","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Xu L, Yu L et al (2019) NOX4 inhibition protects enteric glial cells against Clostridium difficile toxin B toxicity via attenuating oxidative and endoplasmic reticulum stresses. Free Radic Res 53(8):932\u2013940","journal-title":"Free Radic Res"},{"key":"5965_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2021.110123","volume":"87","author":"AP Jim\u00e9nez-Uribe","year":"2021","unstructured":"Jim\u00e9nez-Uribe AP, G\u00f3mez-Sierra T, Aparicio-Trejo OE et al (2021) Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-\u03b2[J]. Cell Signal 87:110123","journal-title":"Cell Signal"},{"issue":"1","key":"5965_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/hep.32221","volume":"76","author":"T Lan","year":"2022","unstructured":"Lan T, Jiang S, Zhang J et al (2022) Breviscapine alleviates NASH by inhibiting TGF-\u03b2-activated kinase 1-dependent signaling. Hepatology 76(1):155\u2013171","journal-title":"Hepatology"},{"key":"5965_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111844","volume":"131","author":"Y Li","year":"2024","unstructured":"Li Y, Long W, Zhang H et al (2024) Irbesartan ameliorates diabetic nephropathy by activating the Nrf2\/Keap1 pathway and suppressing NLRP3 inflammasomes in vivo and in vitro. Int Immunopharmacol 131:111844","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"5965_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1136\/gutjnl-2019-320170","volume":"70","author":"S Monteiro","year":"2021","unstructured":"Monteiro S, Grandt J, Uschner FE et al (2021) Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation[J]. Gut 70(2):379\u2013387","journal-title":"Gut"},{"issue":"10","key":"5965_CR18","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.devcel.2021.03.034","volume":"56","author":"AS Mutlu","year":"2021","unstructured":"Mutlu AS, Duffy J, Wang MC (2021) Lipid metabolism and lipid signals in aging and longevity. Dev Cell 56(10):1394\u20131407","journal-title":"Dev Cell"},{"issue":"5","key":"5965_CR19","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/hep.31173","volume":"72","author":"JM Paik","year":"2012","unstructured":"Paik JM, Golabi P, Younossi Y et al (2012) Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD. Hepatology (Baltimore, MD) 72(5):1605\u20131616","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"17","key":"5965_CR20","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1089\/ars.2013.5619","volume":"20","author":"Y Paik","year":"2014","unstructured":"Paik Y, Kim J, Aoyama T et al (2014) Role of NADPH oxidases in liver fibrosis[J]. Antioxid Redox Signal 20(17):2854\u20132872","journal-title":"Antioxid Redox Signal"},{"key":"5965_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102157","volume":"47","author":"Y Pang","year":"2021","unstructured":"Pang Y, Wu D, Ma Y et al (2021) Reactive oxygen species trigger NF-\u03baB-mediated NLRP3 inflammasome activation involvement in low-dose CdTe QDs exposure-induced hepatotoxicity. Redox Biol 47:102157","journal-title":"Redox Biol"},{"key":"5965_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola M, Pinzani M (2019) Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med 65:37\u201355","journal-title":"Mol Aspects Med"},{"issue":"7","key":"5965_CR23","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/s12276-024-01261-8","volume":"56","author":"R Ramachandran","year":"2024","unstructured":"Ramachandran R, Manan A, Kim J et al (2024) NLRP3 inflammasome: a key player in the pathogenesis of life-style disorders[J]. Exp Mol Med 56(7):1488\u20131500","journal-title":"Exp Mol Med"},{"key":"5965_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.intimp.2018.07.027","volume":"63","author":"W Song","year":"2018","unstructured":"Song W, Wei L, Du Y et al (2018) Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-\u03baB\/p38 signaling pathway in high-fat diet\/streptozotocin-induced diabetic mice. Int Immunopharmacol 63:227\u2013238","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"5965_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP (2019) The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol 19(8):477\u2013489","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"5965_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nri2725","volume":"10","author":"J Tschopp","year":"2010","unstructured":"Tschopp J, Schroder K (2010) NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10(3):210\u2013215","journal-title":"Nat Rev Immunol"},{"key":"5965_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.biopha.2016.11.134","volume":"86","author":"W Wang","year":"2017","unstructured":"Wang W, Wu Q, Sui Y et al (2017) Rutin protects endothelial dysfunction by disturbing Nox4 and ROS-sensitive NLRP3 inflammasome. Biomed Pharmacother 86:32\u201340","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"5965_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jdermsci.2020.03.001","volume":"98","author":"D Wang","year":"2020","unstructured":"Wang D, Duncan B, Li X et al (2020) The role of NLRP3 inflammasome in infection-related, immune-mediated and autoimmune skin diseases[J]. J Dermatol Sci 98(3):146\u2013151","journal-title":"J Dermatol Sci"},{"issue":"1","key":"5965_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41575-018-0055-0","volume":"16","author":"MCS Wong","year":"2019","unstructured":"Wong MCS, Huang JLW, George J et al (2019) The changing epidemiology of liver diseases in the Asia-Pacific region[J]. Nat Rev Gastroenterol Hepatol 16(1):57\u201373","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"5965_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-026-07898-5","volume":"24","author":"Z Xie","year":"2026","unstructured":"Xie Z, Yang M, Liu Z et al (2026) PARK7-Nrf2 axis mitigates NLRP3-driven inflammation to rescue neurovascular unit from hypoxia\/reoxygenation-induced necroptosis. J Transl Med 24(1):445","journal-title":"J Transl Med"},{"issue":"11","key":"5965_CR31","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.it.2019.09.005","volume":"40","author":"Y Xue","year":"2019","unstructured":"Xue Y, Enosi Tuipulotu D, Tan WH et al (2019) Emerging activators and regulators of?inflammasomes and pyroptosis. Trends Immunol 40(11):1035\u20131052","journal-title":"Trends Immunol"},{"issue":"3","key":"5965_CR32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM (2019) Non-alcoholic fatty liver disease - A global public health perspective[J]. J Hepatol 70(3):531\u2013544","journal-title":"J Hepatol"},{"issue":"6","key":"5965_CR33","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi Z, Tacke F, Arrese M et al (2019) Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 69(6):2672\u20132682","journal-title":"Hepatology"},{"key":"5965_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120410","volume":"295","author":"RA Zaghloul","year":"2022","unstructured":"Zaghloul RA, Zaghloul AM, El-Kashef DH (2022) Hepatoprotective effect of Baicalin against thioacetamide-induced cirrhosis in rats: Targeting NOX4\/NF-\u03baB\/NLRP3 inflammasome signaling pathways[J]. Life Sci 295:120410","journal-title":"Life Sci"},{"issue":"2","key":"5965_CR35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ni.1831","volume":"11","author":"R Zhou","year":"2010","unstructured":"Zhou R, Tardivel A, Thorens B et al (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11(2):136\u2013140","journal-title":"Nat Immunol"},{"key":"5965_CR36","doi-asserted-by":"publisher","first-page":"9938392","DOI":"10.1155\/2022\/9938392","volume":"2022","author":"M Zhou","year":"2022","unstructured":"Zhou M, Zhao X, Liao L et al (2022) Forsythiaside A Regulates Activation of Hepatic Stellate Cells by Inhibiting NOX4-Dependent ROS[J]. Oxid Med Cell Longev 2022:9938392","journal-title":"Oxid Med Cell Longev"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05965-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05965-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05965-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:02:00Z","timestamp":1791255720000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05965-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":36,"alternative-id":["5965"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05965-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"7 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study was reviewed and approved by Institutional Animal Care and Use Committee of Hospital (No. CDYFY-IACUC-202410GR027).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}